The Wegovy pill is a distinct oral formulation accessed through a paid Hers membership. Its starting medicine price should be added to the membership and rechecked as the prescribed plan changes.
- Reviewed product
- FDA-approved branded oral semaglutide
- Public price boundary
- Medication advertised from $149/month; membership extra
- Prescription
- Required; eligibility determined clinically
- Research date
- October 8, 2026
Identify the exact product
Hers’ current product page identifies a daily Wegovy pill option. It is not the same product as a compounded sublingual semaglutide preparation or a weekly Wegovy injection. Formulation-specific directions and label information matter when evaluating an oral treatment.[source]
What the evidence applies to
The current Wegovy prescribing information includes instructions and evidence for the relevant formulation. Do not assume an oral product and an injectable are interchangeable by milligrams or that a percentage from one trial applies to every formulation or patient.[source]
Understand the complete cost
The page advertised medication from $149 per month, with a required membership listed at $39 initially and $149 per month afterward. At an unchanged $149 medicine price, simple arithmetic gives $188 in the first month and $298 with standard recurring membership. These are illustrative totals, not a personalized quote.[source]
Care, refills and practical details
Ask the clinician about the practical requirements of taking the oral formulation and how it fits other medicines. This review intentionally does not supply an individual administration or dose-adjustment plan. If instructions are unclear, the prescriber or pharmacist should clarify them before use.[source]
Safety questions come before the price
The prescribing information includes a boxed warning about thyroid C-cell tumors and contraindications for personal or family history of medullary thyroid carcinoma or MEN2. Other warnings and precautions, including gastrointestinal and related complications, require review with a clinician. This is not a complete safety summary; use the linked current label.[source]
Compare a genuinely similar option
A reader wanting a pill can compare other legitimate access routes for the same branded formulation. A reader focused primarily on price should also compare later medicine prices and care charges. Avoid equating a lower-cost unapproved oral preparation with the approved product.
Read the full provider review and the total-cost guide before treating any headline as the complete treatment budget.
Your questions, answered
Is the displayed price my guaranteed total?
No. It is the public price boundary recorded on the review date. The prescribed product, dose, membership, billing period and eligibility can change the amount you pay.
Did you buy or test this treatment?
No. This is a source-based product and access review. We did not obtain a prescription, purchase medication or independently test treatment results.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Accessed October 8, 2026.
- Hers: Wegovy pillCurrent product page and starting medication quote
- Wegovy prescribing informationManufacturer labeling; formulation-specific directions and safety information
- NIDDK: prescription medicines for overweight and obesityEligibility, long-term care, treatment context and insurance questions